The ‘payvider’ health insurance experiment is on the ropes
Bright HealthCare’s decision to exit insurance altogether marks a low point for the payvider model.
Bright HealthCare’s decision to exit insurance altogether marks a low point for the payvider model.
Andreessen Horowitz has shifted its digital health investment strategy to focus on earlier-stage deals. We look at where it has placed its recent bets.
Over 20,000 founders applied to Y Combinator's Winter 2023 cohort. We analyze the 20 healthcare companies that made the cut.
Global digital health funding holds steady at $3.4B in Q1’23 after plummeting for 4 straight quarters.
Generative AI tools that help doctors zoom through tasks like note-taking are proliferating. We break down the market and what could come next.
From drug design to EHR documentation, we break down 7 ways health systems can leverage generative AI — and the vendors building these solutions.
We mined CB Insights business relationship data on Pfizer to highlight who it’s working with and distill its areas of strategic focus.
Despite strong tailwinds, psychedelics companies aren’t attracting investors like they used to.
Lululemon is looking to sell MIRROR. Despite Tonal’s recent down round and Peloton’s share price drop, the activewear brand might still be able to make a gain on the sale of its connected fitness equipment business.
We mined Cigna’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
Andreessen Horowitz has invested in AI companies disrupting the status quo across industries. We break down its top priorities across enterprise tech, healthcare, and beyond.
We mined NVIDIA's acquisitions, investments, and partnerships to discern the company's strategic priorities.
We outline the market outlook for knowledge discovery in the life sciences industry — from investment trends and leading companies to recommendations for players in the space.
We outline the market outlook for cloud R&D software in the life sciences industry — from investment trends and leading companies to recommendations for players in the space.
We outline the market outlook for nature mining in the life sciences industry — from investment trends and leading companies to recommendations for the players in the space.
Artificial intelligence technology is making medical imaging faster, cheaper, and higher-quality. From image enhancement software to portable ultrasounds, we take a look at the startups and solutions reshaping the radiology space.
We identify Vista Equity Partner's top priorities across cybersecurity, financial services, enterprise tech, and more.
AXA Venture Partners has invested in companies addressing some of the most pressing risks across insurance. We break down where the firm is placing its bets and what it means for the industry.
Silicon Valley Bank’s focus on healthcare and life sciences made it a major partner not only to healthcare startups, but also to their VCs. We look at the top investors in SVB’s healthcare inner circle.
We mined UnitedHealth Group's acquisitions, investments, and partnerships to understand how technology is driving its healthcare expansion in 2023 and beyond.
We identify Thoma Bravo's top priorities across cybersecurity, financial services, enterprise software, and more.
From patient data exchanges to developer toolkits, these vendors are working across tech markets to make healthcare data more accessible.
Tech giant Microsoft is growing its presence in the pharmaceutical space. We dig into its strategy here.
We outline the market outlook for telehealth platforms in the healthcare industry — from investment trends and leading companies to recommendations for the players in the space.